MAA
CLVS

Managed Account Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Managed Account Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$426K Sell
4,847
-21,274
-81% -$1.82M ﹤0.01% 2334
2015
Q1 		$1.94M Buy
26,121
+6,194
+31% +$437K ﹤0.01% 1860
2014
Q4 		$1.12M Buy
19,927
+19,473
+4,289% +$1.02M ﹤0.01% 2035
2014
Q3 		$21K Buy
454
+1
+0.2% +$42 ﹤0.01% 2530
2014
Q2 		$19K Sell
453
-566
-56% -$29.2K ﹤0.01% 2517
2014
Q1 		$71K Buy
+1,019
New +$74.8K ﹤0.01% 2336

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Managed Account Advisors's CLVS Position: Q2 2015 in Review

Managed Account Advisors reduced its Clovis Oncology, Inc. (CLVS) stake by 81% in Q2 2015, selling an estimated $1.82M and leaving 4,847 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

Managed Account Advisors first reported a position in CLVS in Q1 2014 and has held it in 6 quarters since. The position peaked at $1.94M in Q1 2015. 176 funds tracked by Wall St. Rank hold CLVS as of Q2 2015.

  • Managed Account Advisors held 4,847 shares of Clovis Oncology, Inc. worth $426K as of Q2 2015.
  • Managed Account Advisors sold 21,274 Clovis Oncology, Inc. shares in Q2 2015, an estimated $1.82M.
  • Clovis Oncology, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2334 holding.
  • Managed Account Advisors first reported a position in Clovis Oncology, Inc. in Q1 2014 and has held it in 6 quarters since.
  • Managed Account Advisors's Clovis Oncology, Inc. position peaked at $1.94M in Q1 2015.
  • 176 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.